These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32232474)

  • 1. Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure.
    Eyal N; Lipsitch M; Smith PG
    J Infect Dis; 2020 May; 221(11):1752-1756. PubMed ID: 32232474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covid-19 vaccine trial protocols released.
    Doshi P
    BMJ; 2020 Oct; 371():m4058. PubMed ID: 33087395
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use.
    Edwards KM; Orenstein WA
    J Pediatr; 2020 Sep; 224():124-128. PubMed ID: 32565096
    [No Abstract]   [Full Text] [Related]  

  • 4. Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events.
    Eyal N
    Ethics Hum Res; 2020 Jul; 42(4):24-34. PubMed ID: 32441894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2: A New Song Recalls an Old Melody.
    Subbarao K
    Cell Host Microbe; 2020 May; 27(5):692-694. PubMed ID: 32407706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 7. Whither COVID-19 vaccines?
    DeFrancesco L
    Nat Biotechnol; 2020 Oct; 38(10):1132-1145. PubMed ID: 32989315
    [No Abstract]   [Full Text] [Related]  

  • 8. Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review).
    Calina D; Docea AO; Petrakis D; Egorov AM; Ishmukhametov AA; Gabibov AG; Shtilman MI; Kostoff R; Carvalho F; Vinceti M; Spandidos DA; Tsatsakis A
    Int J Mol Med; 2020 Jul; 46(1):3-16. PubMed ID: 32377694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vaccine is not too far for COVID-19.
    Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
    J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
    Al-Kassmy J; Pedersen J; Kobinger G
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32784685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine.
    Bull World Health Organ; 2020 Sep; 98(9):588-589. PubMed ID: 33012858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential.
    Krause PR; Fleming TR; Ellenberg SS; Henao-Restrepo AM;
    Lancet; 2020 Nov; 396(10263):1611-1613. PubMed ID: 33125926
    [No Abstract]   [Full Text] [Related]  

  • 13. So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development.
    Grady C; Shah S; Miller F; Danis M; Nicolini M; Ochoa J; Taylor H; Wendler D; Rid A
    Vaccine; 2020 Sep; 38(41):6381-6387. PubMed ID: 32826103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus Vaccine: Light at the End of the Tunnel.
    Ella KM; Mohan VK
    Indian Pediatr; 2020 May; 57(5):407-410. PubMed ID: 32291382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!
    Boudjelal M; Nehdi A; Islam I
    Expert Opin Drug Discov; 2020 Nov; 15(11):1233-1235. PubMed ID: 32543297
    [No Abstract]   [Full Text] [Related]  

  • 16. Tracking a Vaccine and Developing Therapeutics for COVID-19.
    Gould KA
    Dimens Crit Care Nurs; 2020; 39(6):293-297. PubMed ID: 33009266
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 human challenge studies: ethical issues.
    Jamrozik E; Selgelid MJ
    Lancet Infect Dis; 2020 Aug; 20(8):e198-e203. PubMed ID: 32479747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
    Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
    JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.